Application of Ayurvedic Bhasma for the Treatment of Cancer

Author:

Chatterjee Somsuvra1,Ghosh Chandrachur1,Roy Partha12

Affiliation:

1. Molecular Endocrinology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Uttarakhand, India

2. Center for Indian Knowledge Systems, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, India

Abstract

ABSTRACT The application of Ayurvedic Bhasma in cancer treatment has garnered increasing interest due to its potential as an alternative therapeutic approach. Bhasma, a herbo-mineral formulation that consists of bioactive nanoparticles used in traditional Indian medicine, has shown promising preclinical evidence for its anticancer properties. Ayurveda, an ancient medicine system practiced in the Indian subcontinent, has successfully used various formulations to prevent or treat arbuda, which can be correlated with cancer. These formulations include Swarna Bhasma, Heerak Bhasma, Abhrak Bhasma, Manikya Bhasma, Yashada Bhasma, and many more. Using Ayurvedic medicines, the side effects of chemotherapy can be minimized, thereby increasing the life span of patients. With the advent of nanotechnology, traditional drug design and delivery are being looked upon in a completely new perspective. The anticancer activity of certain Bhasma is attributed to the presence of metallic nanoparticle content, enhancing its bioavailability and targeted action on cancer cells. In preclinical studies, some Bhasmas have demonstrated potential in inhibiting cancer cell proliferation, inducing apoptosis, and suppressing tumor growth. However, at the same time, limitations in the use of Bhasma for cancer treatment, such as the lack of standardized synthesis processes and documented scientific validation, have also been acknowledged. The multifaceted analysis presented underscores the need for rigorous research, including clinical trials, to validate the safety, efficacy, and specific applications of Bhasma in different cancer types and stages. Although the health-beneficial effects of these Bhasmas have been known for a long time, their mechanism of action is not clearly understood yet at least for some Bhasmas that have shown potential in clinical trials. Therefore, further detailed studies are needed to understand the therapeutic mode of action for different Bhasma. However, despite these limitations, the integration of Ayurvedic Bhasma into cancer treatment regimens emerges as a compelling prospect, potentially yielding synergistic effects.

Publisher

Medknow

Reference59 articles.

1. Burden of cancers in India – Estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on national cancer registry program;Kulothungan;BMC Cancer,2022

2. Bhasma: The ancient Indian nanomedicine;Pal;J Adv Pharm Technol Res,2014

3. The Ayurvedic bhasma: The ancient science of nanomedicine;Kumar Pal;Recent Pat Nanomed,2015

4. Nanotechnology-finding proofs for its ancient origin;Swati;Asian J Res Pharm Sci,2021

5. Manikya Bhasma is a nanomedicine to affect cancer cell viability through induction of apoptosis;Jha;J Ayurveda Integr Med,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3